Literature DB >> 16861863

Initial experience with intracardiac echocardiography guidance in transcatheter closure of interatrial communication (atrial septal defect, patent foramen ovale, fenestrated Fontan) in Saudi Arabia.

Mashail Alobaidan1, Tarik Moamenah, Hafeez Abdullah.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16861863      PMCID: PMC6074436          DOI: 10.5144/0256-4947.2006.216

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


× No keyword cloud information.
The recent development of intracardiac echocardiography (ICE) has added a further dimension to the imaging modalities available to the cardiologist. Intracardiac ultrasound or echocardiography has been in existence since the 1970s with clinical use for visualization of the coronary arteries since the 1980s.1,2 Early ultrasound-tipped catheters used high frequency for detailed imaging of the coronary artery lumen and wall. However, these ultrasound-tipped catheters lacked good depth penetration, and color and pulse Doppler capabilities. With the introduction of lower frequency catheters, an increase in depth penetration was possible. The initial experience with the use of the catheter for guiding device closure of secundum atrial septal defect (ASD) and patent foramen ovale (PFO) has been recently described. 3 We report our experience using this new modality in guiding trans-catheter closure of ASD, PFO and fenestrated Fontan. We avoided transesophageal echocardiography (TEE) and general anesthesia (except for that needed for comparison of TEE and ICE). We assessed the feasibility and accuracy of ICE in guiding the percutaneous closure of intra-atrial communications and the success of device deployment at Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.

Patients and Methods

High quality ICE imaging was obtained using a 10Fr (3.2 mm), 5.5- to 10-MHz ultrasound tipped catheter (Acuson Corporation). The advantages of this catheter include the presence of a four-way tip articulation for easy maneuverability inside the cardiac chamber and Doppler capabilities. The catheter was introduced via 10Fr sheath from the right or left femoral vein. The catheter was connected to Acuson portable machine. The catheter has a quadirectional steerable tip that houses a side-firming, multiple frequency (5–10 MHz) phased-array transducer with two-dimensional and color Doppler imaging modes. The scan plane is along the axis of the catheter with a range of tissue penetration from 2 to 120 mm. On entering the RA the transducer was rotated anteriorly to obtain an image of the tricuspid valve and right ventricle (RV) inlet. The transducer tip was then flexed posteriorly and rotated clockwise to view the aorta and atrial septum in the long axis. Movement of the catheter cranially and caudally, afforded excellent views of the superior and inferior aspects of the atrial septum. The course of the right-sided pulmonary views could be imaged from the junction of the RA and superior venacava by rotating the catheter clockwise. A short-axis image of the aortic valve and atrial septum was achieved by further posterior flexing and rotating the transducer clockwise, such that the catheter tip was directed toward the TV. The amplatzer septal or PFO occluders were used in all patients. Thirty-nine patients included 13 males, 26 females, 13 PFO closure, 20 ASD II (5 no device + 15 closure), 5 fenestration closure, and 1 fenestration creation. The patient ages ranged from 4 years to 51 years with a mean of 23.5 years. Body weight ranged from 17.2 kilograms to 94 kilograms with a mean of 49 kilograms.
Table 1

Details of diseases in relation to devices and procedures.

No. of PatientsDiseaseDevice sizeProcedure
12PFO35 PFOICE
2ASD II35 (cribriform)ICE
3Fenestration closure4 mmICE
2ASD II40 mmICE + TEE
3ASD II26 mmICE + TEE
1ASD II20 mmICE
2ASD II16 mmICE
1ASD II15 mmICE
1ASD II8 mmICE
1Fontan I6 mmICE
1Fontan I7 mmICE
2ASD II25 ( cribriform)ICE
1PFO25 ( cribriform)ICE
1ASD II14 mmICE
5ASD IINo device (failed)ICE + TEE
1Fenestration fontanNo deviceICE

Results

The ASD cases included 17 patients, 13 of whom were totally occluded with the device (9 with ICE alone, 4 under ICE + TEE). The device used was an Amplatzer device size between 8 and 40 mm (median 24 mm). ICE was used in sizing the ASD and post-device closure. The remaining 4 patients with ASD II failed the closure and were sent for surgical repair. There were 12 patients with PFO occluded under ICE, and we used the Amplatzer device, size 35 mm and 25 mm, cribriform occluder to close the PFO in all patients with or without aneurysm. Four patients with a fenestrated Fontan were occluded under ICE and we attempted 1 fenestration creation under ICE alone using the Amplatzer ASD device occluder size 4 to 7 mm. ICE was done before to measure the size of the fenestration and after the device was implanted to see the leak.

Discussion

As a result of the ease of implantation and the superior success rate of ASD closure with the Amplatzer septal occluder,4,5,6 the transcatheter occlusion of ASD has become widespread and has replaced the routine surgical closure in a lot of centers. The practice of transcatheter closure of ASD is usually performed under general anaesthesia guided by continuous monitoring of TEE. To avoid the need for general anesthesia and for best assessment of the interatrial septum (IAS), ICE was thought to be superior to conventional TEE, and recent study results clearly demonstrate that ICE monitoring in transcatheter closure is superior to TEE.7,8,9
Table 2

Atrial septal defect (ASD) assessment by intracardiac echocardiography (ICE) and transesophageal echocardiography (TEE).

PatientASD (age)AIASDiameter (mm)Device (mm)Flouro time (min)
ICETEEStretched

M12 yrsAbsent7-8817

F12 yrsAbsent2425242615.1

F35 yrsAbsent3838404023.8

F8 yrsAbsent14131581622.4

F6 ½ yrsPresent11-14154.7

F12 yrsPresent22-2525(cribiform)11.2

M42 yrsAbsent3940404011.1

F39 yrsPresent313334357.1

F4 yrsAbsent15-1516(cribiform)9.2

M45 yrsPresent34-3435(cribiform)27.5

F13 yrsAbsent232226-8.9

F46 yrs.Absent423942-2.4

F11 yrsPresent182024-16.5

M13 yrsAbsent25-252612.2

F9 yrsAbsent22&2-23 & 22513.4

F10 yrsAbsent12-12.51414.5

F26 yrsPresent37-38-

M5 yrsAbsent19-192028.7

F48 yrsAbsent24-25269.8

F27 yrsAbsent38-41-

ASD II = atrial septal defect, AIAS = aneurysm interatrial septum

ICE monitoring needs no general anasthesia and permits unlimitted echocardiographic viewing in fully conscious and compliant patients. ICE uses a 10-MHZ tranducer which provides a much higher image resolution than TEE, a fact that also helps to effectively respond to any complication.10 There is no doubt that ICE reduces the stress to the patient and reduces the fluoroscopy time as well as the full length of the procedure. For the interventional cardiologist it has great advantages. In this study we reported on the use of ICE and assess its accuracy in evaluating the IAS and the surrounding structures compared to TEE monitoring in guiding transcatheter device closure of the intratrial defect (ASD, PFO, fenestration). Though the number of patients in which TEE was used was small, there is close agreement between TEE and ICE in their assessment of the IAS and the adequacy of the device position. ICE was found to be superior to TEE in detecting the procedural events that may affect the success of the implantation. These data favor the use of ICE to guide the routine closure of most of ASDs in adult and children without the need for TEE and general anesthesia Initially we felt that TEE was superior in evaluating the IAS, probably because of the limited experience with the use of ICE and because we are more familiar with the use and views of the TEE. However, with time and after comparing both tools, we found it is much easier to get the views and to evaluate the atrial septal rims, except for the antero-superior rim, and the septal flap. Device positioning and procedural events were easier with ICE rather than TEE and pulmonary veins view were much clearer with ICE than the TEE view. Device impingement in both the AV valve (tricuspid and mitral valve) is viewed in both ICE and TEE with almost the same quality. Our study is comparable with Mullin’s,7 Bartel’s,8 and Michael’s9 studies. Mullin et al recently reported successful closure of ASD under guidance with ICE and found that ICE is superior to TEE for evaluation of IAS, number of ASDs and device positioning. However Hijazi in 2001 reported on the failure of ICE to detect the malposition of the device. 11 Padol reported the Italian experience of using ICE and their preference for using it in an interventional procedure.12 ICE was used recently in adults to evaluate the mitral valve (MV) and guided MV balloon valvuloplasty, as well as radiofrequency ablation by an electrophysiologist.13,14,15,16 We therefore conclude that ICE is a safe tool for guiding device closure of the interatrial defect, with better patient tolerance. However, we need more practice with with ICE to facilitate interpretation. We found that ICE provides adequate views and unique images of the atrial communication defect and we could measure the size of the ASD, PFO and fenestrated Fontan accurately.
  13 in total

1.  Images in cardiovascular medicine. Optimal guidance for intimal flap fenestration in aortic dissection by transvenous two-dimensional and Doppler ultrasonography.

Authors:  Thomas Bartel; Holger Eggebrecht; Tiko Ebradlidze; Dietrich Baumgart; Raimund Erbel
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

2.  Intracardiac echocardiography guided device closure of atrial septal defects.

Authors:  Michael J Mullen; Bryan F Dias; Fiona Walker; Samuel C Siu; Lee N Benson; Peter R McLaughlin
Journal:  J Am Coll Cardiol       Date:  2003-01-15       Impact factor: 24.094

3.  Intracardiac echocardiography using the AcuNav ultrasound catheter during percutaneous closure of multiple atrial septal defects.

Authors:  Gian Paolo Ussia; Agata Privitera; Marcello Campisi; Mario Carminati; Francesco De Luca
Journal:  Ital Heart J       Date:  2004-05

4.  Intravascular real-time, two-dimensional echocardiography.

Authors:  J R Roelandt; P W Serruys; N Bom; W G Gussenhoven; C T Lancee; H ten Hoff
Journal:  Int J Card Imaging       Date:  1989

5.  Intracardiac echocardiography to guide transseptal left heart catheterization for radiofrequency catheter ablation.

Authors:  E G Daoud; S J Kalbfleisch; J D Hummel
Journal:  J Cardiovasc Electrophysiol       Date:  1999-03

6.  Initial clinical experience with intracardiac echocardiography in guiding balloon mitral valvuloplasty: technique, safety, utility, and limitations.

Authors:  Nathan E Green; Adam R Hansgen; John D Carroll
Journal:  Catheter Cardiovasc Interv       Date:  2004-11       Impact factor: 2.692

7.  Role of intracardiac echocardiographic guidance in transcatheter closure of atrial septal defects and patent foramen ovale using the Amplatzer device.

Authors:  Peter Koenig; Qi-Ling Cao; Mary Heitschmidt; David J Waight; Ziyad M Hijazi
Journal:  J Interv Cardiol       Date:  2003-02       Impact factor: 2.279

8.  Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications.

Authors:  Thomas Bartel; Thomas Konorza; Jawed Arjumand; Tiko Ebradlidze; Holger Eggebrecht; Guido Caspari; Ulrich Neudorf; Raimund Erbel
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

9.  Transcatheter closure of atrial septal defect in young children: results and follow-up.

Authors:  Gianfranco Butera; Gabriella De Rosa; Massimo Chessa; Luca Rosti; Diana Gabriella Negura; Piazza Luciane; Alessandro Giamberti; Eduardo Bossone; Mario Carminati
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

10.  Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications.

Authors:  Nassir F Marrouche; David O Martin; Oussama Wazni; A Marc Gillinov; Allan Klein; Mandeep Bhargava; Eduardo Saad; Dianna Bash; Hirotsugu Yamada; Wael Jaber; Robert Schweikert; Patrick Tchou; Ahmad Abdul-Karim; Walid Saliba; Andrea Natale
Journal:  Circulation       Date:  2003-05-19       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.